CClinicalTrials.gg
RecruitingNCT04983082CORE-DUpdated Jun 29, 2026

Portsmouth CORE-D Routine Care Data Repository

An observational study in Adult Hospital Patients at Risk of Adverse Outcomes, sponsored by Portsmouth Hospitals NHS Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-06-29.

Sponsored by Portsmouth Hospitals NHS Trust · Observational

From the registry’s dates

  • Started Aug 2021; still recruiting 5 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
750,000
Ages
16 Years and older
Sex
All
01

Study summary

An integrated database of depersonalised routine hospital patient data consisting of demographic and disease attributes, physiological or laboratory measurements, care contacts and interventions along with associated clinical outcomes. The database is an essential resource for the development and testing of risk models and classification systems, modified as necessary for patient subgroups, which can then be introduced into clinical care to improve patient outcomes. It can also be used for large scale simulations to evaluate interventions.

Read the detailed description

The aims and objectives of this database of depersonalised routinely collected hospital patient data are to:

  • Conduct epidemiological and observational studies of acute hospital care.
  • Develop and use algorithms and risk models to identify the deteriorating / sick adult so that interventions and enhanced care can be provided in a timelier manner with consequent resource and outcome improvements. This covers both the deteriorating inpatient at risk of adverse outcomes and people in the local community at risk of hospitalisation or in need of other health services.
  • Retrospectively evaluate interventions e.g. impact of system-wide clinical pathway introduction
  • Conduct simulations of clinical pathways
02

Conditions studied

  • Adult Hospital Patients at Risk of Adverse Outcomes
03

In context

Lead sponsor

Portsmouth Hospitals NHS Trust is the lead sponsor of 74 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

The research database will hold data on adults who are treated by Portsmouth Hospitals University National Health Service Trust (PHU), either as an outpatient, Accident and Emergency (A\&E) attender, day case or inpatient or have investigations carried out by PHU services Adult patients are defined by the National Health Service (NHS) as individuals over 16 years old. Data on service contacts and use will only be included where the patient was more than 16 years old at that time. None of the data included in the Clinical Outcomes analyses are collected specifically for the purposes of research. All datasets are routinely collected clinical datasets, collected for clinical use and clinical audit.

Inclusion criteria

  • Adult presenting at the acute hospital or receiving services from the hospital

Exclusion criteria

Exclusion Criteria:

  • Adults who have registered an opt out of research with National Health Service (NHS) Digital
  • Adults who have contacted the hospital to ask that their records are not to be included in this study
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
750,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. In-hospital death

    Death during hospital admission

    Time frame: At 24 hours after an observation assessment or physiological measurement

  2. In-hospital death

    Death during hospital admission

    Time frame: 30 days after admission

  3. Unanticipated ICU admission

    Unanticipated ICU admission during hospital stay

    Time frame: At 24 hours after an observation assessment or physiological measurement

  4. Unanticipated ICU admission

    Unanticipated ICU admission during hospital stay

    Time frame: 30 days after admission

  5. Cardiac arrest

    Cardiac arrest during hospital stay

    Time frame: At 24 hours after an observation assessment or physiological measurement

  6. Cardiac arrest

    Cardiac arrest during hospital stay

    Time frame: 30 days after admission

Secondary outcomes

  1. Diagnosis of Corona Virus Disease (COVID) infection

    Diagnosis of COVID-19

    Time frame: 48 hours after presentation

  2. Diagnosis of Corona Virus Disease (COVID) infection

    Diagnosis of COVID-19

    Time frame: At 48 hours after an observation assessment or physiological measurement

  3. Detection of Acute Organ Dysfunction

    Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score

    Time frame: 24 hours after presentation

  4. Detection of Acute Organ Dysfunction

    Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score

    Time frame: 48 hours after presentation

  5. Detection of Acute Organ Dysfunction

    Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score

    Time frame: 72 hours after presentation

  6. Detection of Acute Organ Dysfunction

    Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score

    Time frame: 1 week after presentation

  7. Detection of Acute Organ Dysfunction

    Detection of acute organ dysfunction as measured by components of the Sequential Organ Failure Assessment (SOFA) Score

    Time frame: 30 days after presentation

07

Study locations

1 of 1 sites recruiting
  • Queen Alexandra Hospital
    Portsmouth, Hampshire PO6 3LY, United Kingdom
    • Paul E Schmidt · Contact
    • Paul E Schmidt · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Bona fides United Kingdom (UK) researchers can make requests for access. They will be asked to detail their proposal in standard form which will be assessed by a Data Access Committee. Data will only be made available in a fully anonymous form and will be subject to a data sharing agreement.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04983082
Lead sponsor
Portsmouth Hospitals NHS Trust
Responsible party
Sponsor
First posted
Jul 30, 2021
Start date
Aug 19, 2021
Primary completion
Apr 2031 (estimated)
Completion
Apr 2031 (estimated)
Last update
Jun 29, 2026

Study contacts

Paul Meredith, PhD
Contact
paul.meredith@porthosp.nhs.uk
023 92286000 ext. 3774
Alice Mortlock, PhD
Contact
alice.mortlock@porthosp.nhs.uk
023 92286000 ext. 4042
Paul E Schmidt, MRCP
principal investigator · Portsmouth Hospitals NHS Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion